Overview

Efficacy of Varenicline in Ambivalent Smokers

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test whether Varenicline can help ambivalent smokers (those who are interested in quitting at some point in the future but have no current plans to quit) to reduce their smoking and eventually quit.

Phase:

Phase 2

Details

Lead Sponsor:

University of Vermont Medical Center

Collaborator:

Pfizer

Treatments:

Varenicline